GenFleet Therapeutics Sets 21 Aug 2026 Board Meeting to Approve H1 2026 Interim Results and Dividend Plan

Bulletin Express

08/06

GenFleet Therapeutics (Shanghai) Inc. announced that its board of directors will convene on 21 August 2026. The meeting agenda includes:

• Reviewing and approving the consolidated interim results for the six months ended 30 June 2026.

• Considering the declaration of an interim dividend, if any.

The notice was issued by Chairman and Executive Director Dr. Qiang Lu on 6 August 2026.

Current board composition: three executive directors (Dr. Qiang Lu, Dr. Jiong Lan, Ms. Zhang Wei), two non-executive directors (Mr. Zhu Jingyang, Ms. Tao Sha) and three independent non-executive directors (Ms. Christine Shaohua Lu-Wong, Dr. Zhou Demin, Mr. Li Bo).

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/news/1124539406"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1124539406\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1124539406?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-06 06:08","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1124539406","market":"us","top_or_hot":-1,"title":"GenFleet Therapeutics Sets 21 Aug 2026 Board Meeting to Approve H1 2026 Interim Results and Dividend Plan","media":"Bulletin Express","content":"<p>GenFleet Therapeutics (Shanghai) Inc. announced that its board of directors will convene on 21 August 2026. The meeting agenda includes:</p>\n<p>• Reviewing and approving the consolidated interim results for the six months ended 30 June 2026.</p>\n<p>• Considering the declaration of an interim dividend, if any.</p>\n<p>The notice was issued by Chairman and Executive Director Dr. Qiang Lu on 6 August 2026.</p>\n<p>Current board composition: three executive directors (Dr. Qiang Lu, Dr. Jiong Lan, Ms. Zhang Wei), two non-executive directors (Mr. Zhu Jingyang, Ms. Tao Sha) and three independent non-executive directors (Ms. Christine Shaohua Lu-Wong, Dr. Zhou Demin, Mr. Li Bo).</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>GenFleet Therapeutics Sets 21 Aug 2026 Board Meeting to Approve H1 2026 Interim Results and Dividend Plan</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGenFleet Therapeutics Sets 21 Aug 2026 Board Meeting to Approve H1 2026 Interim Results and Dividend Plan\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time smaller\">2026-08-06 06:08</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>GenFleet Therapeutics (Shanghai) Inc. announced that its board of directors will convene on 21 August 2026. The meeting agenda includes:</p>\n<p>• Reviewing and approving the consolidated interim results for the six months ended 30 June 2026.</p>\n<p>• Considering the declaration of an interim dividend, if any.</p>\n<p>The notice was issued by Chairman and Executive Director Dr. Qiang Lu on 6 August 2026.</p>\n<p>Current board composition: three executive directors (Dr. Qiang Lu, Dr. Jiong Lan, Ms. Zhang Wei), two non-executive directors (Mr. Zhu Jingyang, Ms. Tao Sha) and three independent non-executive directors (Ms. Christine Shaohua Lu-Wong, Dr. Zhou Demin, Mr. Li Bo).</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02595","symbol_name":"勁方醫藥-B","start_time":0,"source_url":"","article_id":"1124539406","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1124539406","pubTimestamp":1785967687,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"GenFleet Therapeutics (Shanghai) Inc. announced that its board of directors will convene on 21 August 2026. The meeting agenda includes: • Reviewing and approving the consolidated interim results for...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02595":"劲方医药-B"},"translate_title":"GenFleet Therapeutics 定于 2026 年 8 月 21 日召开董事会会议，批准 2026 年上半年中期业绩和股息计划","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02595":1},"content_text":"GenFleet Therapeutics (Shanghai) Inc. announced that its board of directors will convene on 21 August 2026. The meeting agenda includes:\n• Reviewing and approving the consolidated interim results for the six months ended 30 June 2026.\n• Considering the declaration of an interim dividend, if any.\nThe notice was issued by Chairman and Executive Director Dr. Qiang Lu on 6 August 2026.\nCurrent board composition: three executive directors (Dr. Qiang Lu, Dr. Jiong Lan, Ms. Zhang Wei), two non-executive directors (Mr. Zhu Jingyang, Ms. Tao Sha) and three independent non-executive directors (Ms. Christine Shaohua Lu-Wong, Dr. Zhou Demin, Mr. Li Bo).","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}